| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
NEUROENDOCRINOLOGY |
Departments of Internal Medicine (G.M., M.Y., L.S.S., R.L.D., J.D.M., K.L.P.), Pharmacology (K.L.P.), and Biochemistry (P.A., J.D.M.), University of Texas Southwestern Medical Center, Dallas, Texas 75390; and University of Mississippi Medical Center (E.G.-S.), Jackson, Mississippi 39216
Address all correspondence and requests for reprints to: Dr. Keith L. Parker, University of Texas Southwestern Medical Center, Room J6.106, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8857. E-mail: kparke{at}mednet.swmed.edu
Knockout (KO) mice lacking steroidogenic factor 1 (SF-1) exhibit a phenotype that includes adrenal and gonadal agenesis, impaired gonadotropin expression, and abnormalities of the ventromedial hypothalamic nucleus (VMH). Studies in rodents with lesions of the ventromedial hypothalamus have implicated the VMH in body weight regulation, suggesting that SF-1 KO mice may provide a genetic model of obesity. To prevent death, SF-1 KO mice were rescued with corticosteroid injections, followed by syngeneic adrenal transplants from wild-type (WT) littermates. Corticosterone and ACTH levels in WT and SF-1 KO mice were indistinguishable, documenting restoration of hypothalamic-pituitary-adrenal function. Although weights at earlier ages did not differ significantly from WT littermates, SF-1 KO mice were significantly heavier by 8 wk of age and eventually weighed almost twice as much as WT controls. Obesity in SF-1 KO mice predominantly resulted from decreased activity rather than increased food intake. Leptin was increased markedly, insulin was modestly elevated, and glucose was indistinguishable from WT mice. Although sex steroids in rodents affect weight, ovariectomy did not abolish the weight difference between WT and SF-1 KO mice. These SF-1 KO mice are a genetic model of late-onset obesity that may help elucidate the role of the VMH in weight regulation.
This article has been cited by other articles:
![]() |
L. Zhao, K. W. Kim, Y. Ikeda, K. K. Anderson, L. Beck, S. Chase, S. A. Tobet, and K. L. Parker Central Nervous System-Specific Knockout of Steroidogenic Factor 1 Results in Increased Anxiety-Like Behavior Mol. Endocrinol., June 1, 2008; 22(6): 1403 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Madoux, X. Li, P. Chase, G. Zastrow, M. D. Cameron, J. J. Conkright, P. R. Griffin, S. Thacher, and P. Hodder Potent, Selective and Cell Penetrant Inhibitors of SF-1 by Functional Ultra-High-Throughput Screening Mol. Pharmacol., June 1, 2008; 73(6): 1776 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Roth, B. L. Roland, R. L. Cole, J. L. Trevaskis, C. Weyer, J. E. Koda, C. M. Anderson, D. G. Parkes, and A. D. Baron Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies PNAS, May 20, 2008; 105(20): 7257 - 7262. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Bingham, K. K. Anderson, A. L. Reuter, N. R. Stallings, and K. L. Parker Selective Loss of Leptin Receptors in the Ventromedial Hypothalamic Nucleus Results in Increased Adiposity and a Metabolic Syndrome Endocrinology, May 1, 2008; 149(5): 2138 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Chehab Minireview: Obesity and LipOdystrophy--Where Do the Circles Intersect? Endocrinology, March 1, 2008; 149(3): 925 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Del Tredici, C. B. Andersen, E. A. Currier, S. R. Ohrmund, L. C. Fairbain, B. W. Lund, N. Nash, R. Olsson, and F. Piu Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes Mol. Pharmacol., March 1, 2008; 73(3): 900 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Flanagan-Cato, S. J. Fluharty, E. B. Weinreb, and D. R. LaBelle Food Restriction Alters Neuronal Morphology in the Hypothalamic Ventromedial Nucleus of Male Rats Endocrinology, January 1, 2008; 149(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kurrasch, C. C. Cheung, F. Y. Lee, P. V. Tran, K. Hata, and H. A. Ingraham The Neonatal Ventromedial Hypothalamus Transcriptome Reveals Novel Markers with Spatially Distinct Patterning J. Neurosci., December 12, 2007; 27(50): 13624 - 13634. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Naef and B. Woodside Prolactin/Leptin Interactions in the Control of Food Intake in Rats Endocrinology, December 1, 2007; 148(12): 5977 - 5983. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, E. Bomberg, A. Levine, C. Billington, and C. M. Kotz Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1037 - R1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coutant, D. Mallet, N. Lahlou, N. Bouhours-Nouet, A. Guichet, L. Coupris, A. Croue, and Y. Morel Heterozygous Mutation of Steroidogenic Factor-1 in 46,XY Subjects May Mimic Partial Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2868 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, P. Philibert, B. Ferraz-de-Souza, D. Kelberman, T. Homfray, A. Albanese, V. Molini, N. J. Sebire, S. Einaudi, G. S. Conway, et al. Heterozygous Missense Mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) Are Associated with 46,XY Disorders of Sex Development with Normal Adrenal Function J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 991 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, W.-X. Gu, G. Ozisik, W. S. To, C. J. Owen, J. L. Jameson, and J. C. Achermann Analysis of DAX1 (NR0B1) and Steroidogenic Factor-1 (NR5A1) in Children and Adults with Primary Adrenal Failure: Ten Years' Experience J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3048 - 3054. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. G. McNay, M. Pelling, S. Claxton, F. Guillemot, and S.-L. Ang Mash1 Is Required for Generic and Subtype Differentiation of Hypothalamic Neuroendocrine Cells Mol. Endocrinol., July 1, 2006; 20(7): 1623 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shima, M. Zubair, S. Ishihara, Y. Shinohara, S. Oka, S. Kimura, S. Okamoto, Y. Minokoshi, S. Suita, and K.-i. Morohashi Ventromedial Hypothalamic Nucleus-Specific Enhancer of Ad4BP/SF-1 Gene Mol. Endocrinol., November 1, 2005; 19(11): 2812 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takamoto, I. Kurihara, K. Lee, F. J. DeMayo, M.-J. Tsai, and S. Y. Tsai Haploinsufficiency of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Female Reproduction Mol. Endocrinol., September 1, 2005; 19(9): 2299 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, C. Zhang, A. Marimuthu, H. I. Krupka, M. Tabrizizad, R. Shelloe, U. Mehra, K. Eng, H. Nguyen, C. Settachatgul, et al. The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1 PNAS, May 24, 2005; 102(21): 7505 - 7510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Segal, N. R. Stallings, C. E. Lee, L. Zhao, N. Socci, A. Viale, T. M. Harris, M. B. Soares, G. Childs, J. K. Elmquist, et al. Use of Laser-Capture Microdissection for the Identification of Marker Genes for the Ventromedial Hypothalamic Nucleus J. Neurosci., April 20, 2005; 25(16): 4181 - 4188. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hasegawa, M. Fukami, N. Sato, N. Katsumata, G. Sasaki, K. Fukutani, K.-I. Morohashi, and T. Ogata Testicular Dysgenesis without Adrenal Insufficiency in a 46,XY Patient with a Heterozygous Inactive Mutation of Steroidogenic Factor-1 J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5930 - 5935. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Holder Jr, L. Zhang, B. M. Kublaoui, R. J. DiLeone, O. K. Oz, C. H. Bair, Y.-H. Lee, and A. R. Zinn Sim1 gene dosage modulates the homeostatic feeding response to increased dietary fat in mice Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E105 - E113. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Correa, S. Domenice, N. C. Bingham, A. E. C. Billerbeck, W. E. Rainey, K. L. Parker, and B. B. Mendonca A Microdeletion in the Ligand Binding Domain of Human Steroidogenic Factor 1 Causes XY Sex Reversal without Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1767 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Borud, G. Mellgren, J. Lund, and M. Bakke Cloning and Characterization of a Novel Zinc Finger Protein that Modulates the Transcriptional Activity of Nuclear Receptors Mol. Endocrinol., November 1, 2003; 17(11): 2303 - 2319. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |